Literature DB >> 10540334

Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells.

H Mühl1, M Nold, J H Chang, S Frank, W Eberhardt, J Pfeilschifter.   

Abstract

To characterize mechanisms which may determine the fate of apoptotic cells, we investigated chemokine expression in apoptotic promonocytic U937 cells or peripheral blood mononuclear cells (PBMC). Exposure of U937 cells to etoposide (VP-16) or the nitric oxide (NO) donor DETA-NO, both inducers of apoptosis in these cells, was associated with increased expression of the chemokines IL-8 and macrophage inflammatory protein-1 alpha. Up-regulation of IL-8 mRNA expression by VP-16 or DETA-NO was observed as early as 4 h or 6 h, respectively, after onset of treatment and was still detectable after 19 h of exposure. A serine protease inhibitor prevented both VP-16-induced apoptosis and release of IL-8, whereas inhibition of p38 MAP kinases reduced IL-8 secretion only. Moreover, we observed that incubation with 2-chlorodeoxyadenosine (CdA) up-regulated release of IL-8 from adherent PBMC in parallel to induction of apoptosis. In these cells a modest but significant induction of TNF-alpha release by CdA was also detected. In addition, CdA augmented release of IL-8 from whole blood cultures. By facilitating adequate recruitment of phagocytes to sites of cell death, stress-induced up-regulation of chemokines associated with apoptosis may contribute to mechanisms aiming at efficient removal of apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540334     DOI: 10.1002/(SICI)1521-4141(199910)29:10<3225::AID-IMMU3225>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?

Authors:  Christopher D Gregory; Andrew Devitt
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

2.  Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.

Authors:  T Abramson; H Kedem; D A Relman
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis.

Authors:  Liang Liu; Lin Yang; Wei Yan; Jing Zhai; Donald P Pizzo; Peiguo Chu; Andrew R Chin; Meng Shen; Chuan Dong; Xianhui Ruan; Xiubao Ren; George Somlo; Shizhen Emily Wang
Journal:  Clin Cancer Res       Date:  2018-03-02       Impact factor: 12.531

4.  Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus.

Authors:  S-C Hsieh; H-S Yu; W-W Lin; K-H Sun; C-Y Tsai; D-F Huang; Y-Y Tsai; C-L Yu
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

5.  A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin.

Authors:  Stefania Merighi; Carolina Simioni; Stefania Gessi; Katia Varani; Prisco Mirandola; Mojgan Aghazadeh Tabrizi; Pier Giovanni Baraldi; Pier Andrea Borea
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

6.  Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue?

Authors:  Lisa J Wood; Lillian M Nail; Kerri A Winters
Journal:  Oncol Nurs Forum       Date:  2009-09       Impact factor: 2.172

7.  Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity.

Authors:  Collin R Elsea; Daniel A Roberts; Brian J Druker; Lisa J Wood
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

Review 8.  Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning.

Authors:  Masahiro Imamura; Akio Shigematsu
Journal:  Exp Hematol Oncol       Date:  2015-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.